
Refladro-MF Tablet
Marketer
Reflaction Healthcare
Salt Composition
Drotaverine (80mg) + Mefenamic Acid (250mg)
Overview Refladro-MF Tablet
Combiflam-A, a multi-component medication, addresses abdominal pain. Its mechanism involves easing stomach and intestinal muscle contractions, thereby alleviating pain, distension, discomfort, and spasms. It further inhibits specific pain-signaling neurochemicals. Combiflam-A should be taken with meals, following your physician's prescribed dosage and duration. Dosage is tailored to your individual response and condition; continued use as directed is crucial to prevent symptom recurrence and potential worsening. Inform your healthcare provider of all other medications you are using, as interactions are possible. Common, typically transient, side effects include diarrhea, nausea, vomiting, abdominal pain, dry mouth, appetite loss, thirst, and heartburn. Report any concerning side effects promptly. Dizziness and somnolence are also potential effects; avoid driving or mentally demanding tasks until their impact is known. Alcohol consumption should be avoided due to potential increased dizziness. Prior to commencing treatment, disclose any pregnancy, pregnancy plans, breastfeeding, kidney, or liver conditions to allow for appropriate dosage adjustment.
Uses of Refladro-MF Tablet
Managing abdominal discomfort
Major Benefits of Refladro-MF Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Refladro-MF Tablets should be administered with food.
Common Side effects of Refladro-MF Tablet:
- Nausea
- Vomiting
- Diarrhea
- Dryness in mouth
- Heartburn
- Vertigo
- Insomnia (difficulty in sleeping)
- Hypotension (low blood pressure)
- Fast heart rate
- Sweating
- Constipation
- Increased liver enzymes
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Purpura
- Agranulocytosis (deficiency of granulocytes in the blood)
- Breathlessness
- Ringing in ear
- Abdominal pain
- Flatulence
- Indigestion
- Stomach inflammation
- Confusion
- Depression
How to use Refladro-MF Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Refladro-MF Tablets should be administered with a meal.
How Refladro-MF Tablet works:
Combiflam-D, a dual-action tablet, combines Drotaverine and Mefenamic Acid to alleviate abdominal discomfort and cramping. Drotaverine, an antispasmodic agent, targets and reduces painful abdominal muscle contractions. Mefenamic Acid, a non-steroidal anti-inflammatory drug (NSAID), inhibits the production of substances triggering abdominal pain and inflammation.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Refladro-MF Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Refladro-MF Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any hazards before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Refladro-MF Tablet use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by Refladro-MF Tablet side effects, including potential vertigo.
KidneyCAUTION
Patients with kidney impairment should use Refladro-MF Tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Refladro-MF Tablets are contraindicated in individuals with severe kidney disease.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Refladro-MF Tablets. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Refladro-MF Tablet :
Should you forget a Refladro-MF Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Refladro-MF Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
